The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015

被引:203
作者
Jagust, William J. [1 ]
Landau, Susan M. [1 ]
Koeppe, Robert A. [2 ]
Reiman, Eric M. [3 ]
Chen, Kewei [3 ]
Mathis, Chester A. [4 ]
Price, Julie C. [4 ]
Foster, Norman L. [5 ]
Wang, Angela Y. [5 ]
机构
[1] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA
[2] Univ Michigan, Dept Radiol, Div Nucl Med, Ann Arbor, MI 48109 USA
[3] Banner Alzheimer Inst, Phoenix, AZ USA
[4] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA
[5] Univ Utah, Ctr Alzheimers Care Imaging & Res, Dept Neurol, Salt Lake City, UT USA
关键词
PET imaging; Amyloid; Fluorodeoxyglucose; Mild cognitive impairment; Alzheimer's disease; MILD COGNITIVE IMPAIRMENT; WHITE-MATTER REFERENCE; AMYLOID-BETA; HYPOTHETICAL MODEL; BIOMARKERS; TAU; MODERATE; PATHOLOGY; C-11-PIB; VOLUME;
D O I
10.1016/j.jalz.2015.05.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: This article reviews the work done in the Alzheimer's Disease Neuroimaging Initiative positron emission tomography (ADNI PET) core over the past 5 years, largely concerning techniques, methods, and results related to amyloid imaging in ADNI. Methods: The PET Core has used [F-18]florbetapir routinely on ADNI participants, with over 1600 scans available for download. Four different laboratories are involved in data analysis, and have examined factors such as longitudinal florbetapir analysis, use of [F-18]fluorodeoxyglucose (FDG)-PET in clinical trials, and relationships between different biomarkers and cognition. Results: Converging evidence from the PET Core has indicated that cross-sectional and longitudinal florbetapir analyses require different reference regions. Studies have also examined the relationship between florbetapir data obtained immediately after injection, which reflects perfusion, and FDG-PET results. Finally, standardization has included the translation of florbetapir PET data to a centiloid scale. Conclusion: The PET Core has demonstrated a variety of methods for the standardization of biomarkers such as florbetapir PET in a multicenter setting. (C) 2015 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:757 / 771
页数:15
相关论文
共 50 条
[1]  
Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO
[2]  
2-G
[3]   The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes [J].
Beckett, Laurel A. ;
Harvey, Danielle J. ;
Gamst, Anthony ;
Donohue, Michael ;
Kornak, John ;
Zhang, Hao ;
Kuo, Julie H. .
ALZHEIMERS & DEMENTIA, 2010, 6 (03) :257-264
[4]   Improved longitudinal [18F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction [J].
Brendel, Matthias ;
Hoegenauer, Marcus ;
Delker, Andreas ;
Sauerbeck, Julia ;
Bartenstein, Peter ;
Seibyl, John ;
Rominger, Axel .
NEUROIMAGE, 2015, 108 :450-459
[5]   Summary Metrics to Assess Alzheimer Disease Related Hypometabolic Pattern with 18F-FDG PET: Head-to-Head Comparison [J].
Caroli, Anna ;
Prestia, Annapaola ;
Chen, Kewei ;
Ayutyanont, Napatkamon ;
Landau, Susan M. ;
Madison, Cindee M. ;
Haense, Cathleen ;
Herholz, Karl ;
Nobili, Flavio ;
Reiman, Eric M. ;
Jagust, William J. ;
Frisoni, Giovanni B. .
JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (04) :592-600
[6]   Improved Power for Characterizing Longitudinal Amyloid-β PET Changes and Evaluating Amyloid-Modifying Treatments with a Cerebral White Matter Reference Region [J].
Chen, Kewei ;
Roontiva, Auttawut ;
Thiyyagura, Pradeep ;
Lee, Wendy ;
Liu, Xiaofen ;
Ayutyanont, Napatkamon ;
Protas, Hillary ;
Luo, Ji Luo ;
Bauer, Robert ;
Reschke, Cole ;
Bandy, Daniel ;
Koeppe, Robert A. ;
Fleisher, Adam S. ;
Caselli, Richard J. ;
Landau, Susan ;
Jagust, William J. ;
Weiner, Michael W. ;
Reiman, Eric M. .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (04) :560-566
[7]   Characterizing Alzheimer's disease using a hypometabolic convergence index [J].
Chen, Kewei ;
Ayutyanont, Napatkamon ;
Langbaum, Jessica B. S. ;
Fleisher, Adam S. ;
Reschke, Cole ;
Lee, Wendy ;
Liu, Xiaofen ;
Bandy, Dan ;
Alexander, Gene E. ;
Thompson, Paul M. ;
Shaw, Leslie ;
Trojanowski, John Q. ;
Jack, Clifford R., Jr. ;
Landau, Susan M. ;
Foster, Norman L. ;
Harvey, Danielle J. ;
Weiner, Michael W. ;
Koeppe, Robert A. ;
Jagust, William J. ;
Reiman, Eric M. .
NEUROIMAGE, 2011, 56 (01) :52-60
[8]   Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative [J].
Chen, Kewei ;
Langbaum, Jessica B. S. ;
Fleisher, Adam S. ;
Ayutyanont, Napatkamon ;
Reschke, Cole ;
Lee, Wendy ;
Liu, Xiaofen ;
Bandy, Dan ;
Alexander, Gene E. ;
Thompson, Paul M. ;
Foster, Norman L. ;
Harvey, Danielle J. ;
de Leon, Mony J. ;
Koeppe, Robert A. ;
Jagust, William J. ;
Weiner, Michael W. ;
Reiman, Eric M. .
NEUROIMAGE, 2010, 51 (02) :654-664
[9]   Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807 [J].
Chien, David T. ;
Bahri, Shadfar ;
Szardenings, A. Katrin ;
Walsh, Joseph C. ;
Mu, Fanrong ;
Su, Min-Ying ;
Shankle, William R. ;
Elizarov, Arkadij ;
Kolb, Hartmuth C. .
JOURNAL OF ALZHEIMERS DISEASE, 2013, 34 (02) :457-468
[10]   Associations Between Biomarkers and Age in the Presenilin 1 E280A Autosomal Dominant Alzheimer Disease Kindred A Cross-sectional Study [J].
Fleisher, Adam S. ;
Chen, Kewei ;
Quiroz, Yakeel T. ;
Jakimovich, Laura J. ;
Gutierrez Gomez, Madelyn ;
Langois, Carolyn M. ;
Langbaum, Jessica B. S. ;
Roontiva, Auttawut ;
Thiyyagura, Pradeep ;
Lee, Wendy ;
Ayutyanont, Napatkamon ;
Lopez, Liliana ;
Moreno, Sonia ;
Munoz, Claudia ;
Tirado, Victoria ;
Acosta-Baena, Natalia ;
Fagan, Anne M. ;
Giraldo, Margarita ;
Garcia, Gloria ;
Huentelman, Matthew J. ;
Tariot, Pierre N. ;
Lopera, Francisco ;
Reiman, Eric M. .
JAMA NEUROLOGY, 2015, 72 (03) :316-324